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Tracing Uncontrolled Asthma 
in Family Practice Using a Mailed 
Asthma Control Questionnaire
ABSTRACT
PURPOSE A substantial proportion of adult patients with asthma have inad-
equately controlled symptoms despite the availability of effective treatment. The 
Asthma Control Questionnaire (ACQ) can be used to discriminate between asthma 
patients with well- and suboptimally controlled asthma symptoms. The objective 
of this study was to investigate whether a postal mailing of the ACQ can be used 
to identify asthma patients with suboptimal symptom control in family practice. 
METHODS In this observational study, we sent 434 asthma patients from 6 Dutch 
family practices an ACQ by mail to measure control of their asthma symptoms. 
Both respondents and nonrespondents were characterized by information gathered 
from their medical records. Patients with an ACQ sum score (total score) of greater 
than 3 were considered to have suboptimally controlled asthma symptoms.
RESULTS The response rate was 77%. Respondents were more likely than non-
respondents to be female and to use asthma medication. The mean ACQ sum 
score of the respondents was 5.2. Of this group, 53.4% (95% confi dence inter-
val, 48.0%-58.8%) had suboptimally controlled asthma symptoms. Of the 168 
respondents who had not visited their family physician in the 2 years before the 
study, 42.9% (95% confi dence interval, 35.4%-50.4%) had inadequate asthma 
symptom control.
CONCLUSIONS Our results show that a postal mailing of the ACQ is an effective 
approach for tracing asthma patients who need medical attention. It also traces 
patients who would otherwise not have consulted their family physician. The ACQ 
seems to be a useful starting point for health care professionals in family practice 
to improve the level of asthma symptom control in their patient population.
Ann Fam Med 2008;6(suppl 1):s16-s22. DOI: 10.1370/afm.776.
INTRODUCTION
Population surveys have shown that despite the availability of highly effective pharmacotherapy, the majority (up to 70%-95%) of all asthma patients in western Europe and the Asia-Paciﬁ c region have 
signs of poor asthma control.1-3 Known causes of this suboptimal level 
of asthma control are poor adherence to periodic management visits to 
health care professionals4-6 or insufﬁ cient compliance with prescribed 
asthma medication, especially inhaled corticosteroids.5 In addition, 
patients with asthma—and their physicians—tend to overestimate their 
level of asthma control.7,8 These factors emphasize the need to improve 
the identiﬁ cation of poor asthma control and subsequent treatment. 
Because the majority of patients with asthma are treated by family physi-
cians, family practice would be the most appropriate setting to study the 
tracing of patients with poor asthma control. 
Bronchial inﬂ ammation is a marker of asthma control that can be 
assessed by induced sputum eosinophilia9 or bronchial hyperrespon-
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siveness.10 The requirement of laboratory facilities, 
the time-consuming nature of these tests, and their 
unfriendliness to patients severely hamper their routine 
use in primary care, however. An increase of asthma 
symptoms has been shown to indicate a loss of asthma 
control,11,12 making measurement of changes in symp-
toms an attractive alternative to the above tests.
In a previous study,13 we found that the Asthma Con-
trol Questionnaire (ACQ)14-16 can be used to distinguish 
asthma patients with good symptom control from those 
with suboptimal symptom control. The aim of the cur-
rent study was to investigate whether a mailing of the 
ACQ can be used to trace asthma patients with subopti-
mal symptom control in the family practice population.
METHODS
Design and Patient Recruitment
This was a multicenter observational study conducted 
in 6 family practices from the Amsterdam (n = 3) and 
Nijmegen (n = 3) regions in the Netherlands. In the 
Netherlands, patients are registered with a family phy-
sician, who largely coordinates access to health care 
services. The study was approved by the medical eth-
ics review board of the Radboud University Nijmegen 
Medical Centre. 
We selected patients with asthma from the practices’ 
computerized medical records using 2 inclusion criteria: 
(1) an age of 18 to 45 years and (2) a diagnostic label of 
asthma and/or, during the 2 years preceding the study, 
at least 1 prescription for an inhaled corticosteroid and/
or at least 2 prescriptions for an inhaled bronchodila-
tor. The family physicians received a list of all selected 
patients in their practice and were asked to exclude any 
who had a diagnosis of chronic obstructive pulmonary 
disease or who were unable to communicate in Dutch. 
Measures
For all patients, we extracted the following informa-
tion from their family practice medical records: (1) sex, 
(2) age, and (3) in the 2 years preceding the study, num-
ber of visits to the family physician for asthma-related 
complaints, asthma exacerbations, prescriptions for 
asthma medication (β2 agonists, anticholinergics, inhaled 
and oral corticosteroids, cromoglycates, leukotriene 
antagonists), referrals to chest physicians, asthma-related 
emergency department visits, and hospital admissions.
In an initial mailing, patients were sent the ACQ 
from their family physician with a cover letter and a 
prepaid return envelope. In a reminder mailing, sent to 
patients who had not responded 4 weeks after the initial 
mailing, patients received a reminder letter along with 
another ACQ and another prepaid return envelope.
The ACQ14 contains a set of questions that allow 
patients with asthma to rate the severity of their respi-
ratory symptoms (Table 1). Patients are asked to recall 
their respiratory health status during the previous week 
and respond to each question on a 7-point scale rang-
ing from 0 (well controlled) to 6 (extremely poorly 
controlled). The ACQ has been validated and has been 
Table 1. Asthma Control Questionnaire16-18
1.  On average, dur-
ing the past week, 
how often were you 
woken by your 
asthma during the 
night?
0 Never
1 Hardly ever
2 A few times
3 Several times
4 Many times
5 A great many times
6  Unable to sleep because 
of asthma
4.  In general, during the past 
week, how much short-
ness of breath did you 
experience because of 
your asthma?
0 None
1 A very little
2 A little
3 A moderate amount
4 Quite a lot
5 A great deal
6 A very great deal
2.  On average, during 
the past week, how 
bad were your 
asthma symptoms 
when you woke 
up in the morning?
0 No symptoms
1 Very mild symptoms
2 Mild symptoms
3 Moderate symptoms
4 Quite severe symptoms
5 Severe symptoms
6 Very severe symptoms
5.  In general, during the past 
week, how much of the 
time did you wheeze?
0 Never
1 Hardly any of the time
2 A little of the time
3 A moderate amount of the time
4 A lot of the time
5 Most of the time
6 All the time
3.  In general, during 
the past week, how 
limited were you 
in your activities 
because of your 
asthma?
0 Not limited at all
1 Very slightly limited
2 Slightly limited
3 Moderately limited
4 Very limited
5 Extremely limited
6 Totally limited
6.  On average, during the 
past week, how many 
puffs/inhalations of 
short-acting bronchodila-
tor (eg, Ventolin, Bricanyl) 
have you used each day?
(If you are not sure how to 
answer this question, please 
ask for help.)
0 None
1 1-2 puffs/inhalations most days
2 3-4 puffs/inhalations most days
3 5-8 puffs/inhalations most days
4 9-12 puffs/inhalations most days
5 13-16 puffs/inhalations most days
6 More than 16 puffs/inhalations most days
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used to measure the effects of asthma treatment in 
clinical studies.14-17 Initially, the questionnaire included 
a question on pulmonary function, but omission of that 
question did not inﬂ uence the validity of the ACQ.16,18 
The questionnaire was therefore modiﬁ ed to the 6-
question ACQ used in this study.16-18 
Analysis
We used the sum score (total score) of the ACQ’s 6 
questions (range, 0-36 points)—instead of the mean 
score, which is generally used—because this is easier to 
calculate in daily practice. As long as patients answer 
all questions, the interpretation is the same. The higher 
the sum score, the poorer patients’ asthma control.
In a previously reported pilot study,13 we estab-
lished an ACQ cutoff value for identifying patients 
with asthma who have suboptimal control of their 
symptoms. A sum score of 3 points or less best indi-
cated good asthma symptom control, having a sensitiv-
ity of 84% and a speciﬁ city of 76%. 
A primary respondent was deﬁ ned as a patient who 
returned the ACQ after the ﬁ rst mailing, and a second-
ary respondent was deﬁ ned as a patient who returned the 
ACQ after the reminder mailing. Nonrespondents 
were patients who did not return the ques-
tionnaire after these 2 consecutive attempts. 
Patients who had visited their family physician 
for asthma-related complaints during the 2-year 
period before the mailing were deﬁ ned as visi-
tors, and those who had not were deﬁ ned as 
nonvisitors. 
We performed data analysis with SPSS 
version 12.0 for Microsoft Windows (SPSS 
Inc, Chicago, Illinois). Various study groups 
were compared with regard to the informa-
tion extracted from their medical records 
and—apart from the nonrespondents—their 
ACQ sum scores. Speciﬁ cally, we compared 
differences between respondents overall and 
nonrespondents, between primary and sec-
ondary respondents, and between visitors and 
nonvisitors using the χ2, Mann Whitney U, 
and 1-way ANOVA statistical tests. A 95% 
conﬁ dence interval (CI) was calculated for the 
most relevant proportions.
RESULTS
Mailing Response and Study Population
We identiﬁ ed and sent the ACQ to 434 
patients with asthma from the 6 family prac-
tices who met the inclusion and exclusion 
criteria. Patient ﬂ ow in the study is shown 
in Figure 1. A total of 333 patients or 76.7% 
(95% CI, 72.7%-80.7%) of all patients who were sent 
the ACQ returned it. 
Characteristics of the respondents overall and non-
respondents are shown in Table 2. Compared with non-
respondents, respondents were more likely to be female 
(62.5% vs 45.5%), were slightly older (34.6 vs 32.6 
years), and were more likely to be using asthma medica-
tion in general (79.6% vs 61.4%) and inhaled corticoste-
roids in particular (28.8% vs 16.8%). We found no other 
statistically signiﬁ cant differences between these groups.
Characteristics of the primary respondents and sec-
ondary respondents are shown in Table 3. Compared 
with secondary respondents, primary respondents 
consulted their family physician more frequently (1.3 
vs 0.8 times in the preceding 2 years) and were more 
likely to be using any asthma medication (83.2% vs 
69.7%). These groups were otherwise statistically 
indistinguishable. 
Symptom Control in Respondents 
and Nonrespondents
In the 2 years preceding the mailing, in the nonrespon-
dent group, 1 patient had been admitted to the hospital 
Figure 1. Patient fl ow. 
ACQ = Asthma Control Questionnaire.14,16
Asthma patients registered in 
6 family practices on fi nal mailing lists
N = 434
Initial postal mailing of ACQ
Primary respondents
n = 244 (56.2%)
Complete ACQ: n = 241 (98.8%)
Total respondents
n = 333 (76.7%)
Complete ACQ: n = 326 (97.9%)
Incomplete ACQ: n = 7 (2.1%)
Total nonrespondents
n = 101 (23.3%)
Secondary respondents
n = 89 (20.5%)
Complete ACQ: n = 85 (95.5%)
Incomplete ACQ: n = 4 (4.5%)
Initial nonrespondents
n = 190 (43.8%)
Reminder mailing of ACQ
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and 1 patient had visited an emergency department 
because of an acute asthma attack. None of the patients 
in the respondent group had experienced either of 
these events. 
The mean ACQ sum score of the respondents was 
5.2 points (Table 2). Secondary respondents had a 
lower ACQ sum score than primary respondents (4.8 
vs 5.3 points), although the difference was not sig-
niﬁ cant (Table 3). The distribution of the ACQ sum 
scores among all respondents is depicted in Figure 
2. When primary and secondary respondents with a 
complete ACQ were combined (n = 326), fully 53.4% 
(95% CI, 48.0%-58.8%) of respondents had symptoms 
of suboptimally controlled asthma (ie, an ACQ sum 
score >3 points). 
Symptom Control in Visitors and Nonvisitors
A total of 207 of the patients who received the mailed 
ACQ from their family physician, or 47.7% (95% CI, 
43.0%-52.4%), met the deﬁ nition of visitors because 
they had at least 1 documented asthma-related family 
physician visit during the preceding 2 years. Of the 
174 respondents with suboptimally controlled symp-
toms, 58.6% had at least 1 visit. According to their 
medical records, visitors had had an average of 2.4 
(SD, 2.0) asthma-related consultations. 
Patients completing the ACQ were nearly equally 
split by visitation status: 158 (48.4%) were visitors and 
168 (51.6%) were nonvisitors. Compared with the visi-
tors, the nonvisitors had better asthma symptom control: 
the mean ACQ sum score was 3.9 points (SD, 4.5) for 
nonvisitors and 6.5 points (SD, 5.6) for visitors (P <.001). 
Still, 42.9% (95% CI, 35.4%-50.4%) of the 168 nonvisi-
tors who returned their ACQ had suboptimal symptom 
control (ie, an ACQ sum score >3 points), although this 
was less than the 64.6% value among visitors.
DISCUSSION 
A main goal in the management of asthma is to 
achieve optimal control of respiratory symptoms,20 but 
recent surveys show that there is considerable room 
for improvement with regard to the level of asthma 
control in the general population.1-3 As best we could 
determine, no other studies have attempted to identify 
patients with poor asthma symptom control in a pri-
mary care setting with the aid of a simple method. The 
main objective of our study, therefore, was to evalu-
ate whether a mailing of the 
ACQ can be used to identify 
patients with suboptimal 
symptom control among all 
patients registered in a family 
practice who have asthma. 
With the ACQ mailing, 
we were able to reach 77% 
of all the asthma patients 
registered in the participating 
family practices, including a 
rather large group of patients 
who had not had a single con-
tact for respiratory complaints 
with their family physician in 
the past 2 years. When using 
our previously determined 
cutoff value of an ACQ sum 
score of greater than 3, we 
found that about 1 out of 
every 2 asthma patients (53%) 
in these family practices were 
classiﬁ ed as having subop-
timally controlled asthma 
symptoms. A somewhat 
higher prevalence of subopti-
mal asthma control (60%) has 
been reported earlier.21 
Other researchers have 
found that the cutoff value 
Table 2. Characteristics of All Patients Sent the ACQ and of Respondents 
and Nonrespondents
Characteristic
Total
(N = 434)
Group
P Value
Nonrespondents
(n = 101)
Respondents*
(n = 333)
Female 58.5 (254) 45.5 (46) 62.5 (208) .003†
Age, mean (SD), years 34.1 (7.5) 32.6 (7.5) 34.6 (7.5) .02‡
Visitors§ 47.7 (207) 47.5 (48) 47.7 (159) .97†
Consultations,ll mean (SD), No. 1.1 (1.8) 1.0 (1.6) 1.2 (1.9) .45¶
Use of any asthma medication# 75.3 (327) 61.4 (62) 79.6 (265) <.001†
Use of inhaled steroid 26.0 (113) 16.8 (17) 28.8 (96) .02†
Low dose** 8.5 (37) 17.6 (3) 35.8 (34) –
Intermediate dose** 9.4 (41) 29.5 (5) 37.9 (36) .08†
High dose** 7.8 (34) 52.9 (9) 26.4 (25) –
Short-acting bronchodilator 23.7 (103) 19.8 (20) 24.9 (83) .29†
Long-acting β2 agonist 6.0 (26) 5.0 (5) 6.3 (21) .61†
Asthma exacerbation†† 12.0 (52) 8.9 (9) 12.9 (43) .28†
ACQ sum score, mean (SD) – – 5.2 (5.2) –
ACQ = Asthma Control Questionnaire.14,16
Note: Values are % (No.) unless indicated otherwise.
* Primary and secondary respondents combined.
† Calculated with the χ2 test.
‡ Calculated with the 1-way analysis of variance test.
§ Patients who visited their family physician for respiratory complaints, including visits for asthma exacerbations.
ll In the 2 years preceding the ACQ mailing.
¶ Calculated with the Mann-Whitney U test.
# Receipt of at least 1 prescription for a bronchodilator or an inhaled steroid in the 2 years preceding the ACQ 
mailing.
** Proportion of inhaled steroid users; dosing groups are based on the Global Initiative for Asthma (GINA) 
classifi cation.19
†† At least 1 exacerbation for which prednisolone or antibiotics were prescribed. 
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of 3 has as sensitivity of 90% and a speciﬁ city of 
58%17; however, the ACQ cutoff value that is most 
appropriate depends on the health care professional’s 
goals. When resources are limited, the goal might be 
to identify only patients with very poorly controlled 
asthma symptoms, and a higher ACQ cutoff might be 
more appropriate.13 
An interesting observation was that a substantial 
proportion of the visitors (65%) still had suboptimal 
symptom control. In fact, this proportion was even 
greater than that among the nonvisitors (43%). From 
these ﬁ ndings, we conclude that the largest number 
of patients with suboptimal control of their asthma 
was found among those who had visited their fam-
ily physician recently for asthma. This association 
indicates that regular consultation of the family physi-
cian does not always indicate well-controlled asthma. 
It has previously been shown that patients as well as 
their physicians do not always adequately recognize 
suboptimal asthma control,7,8 which possibly explains 
part of this pattern. On the other hand, 
because asthma is usually treated as an 
episodic disorder, asthma patients who 
visit their family physician probably have 
more asthma-related problems. This study 
provides empiric data that this is the case, 
but also that the situation is more complex 
than that, given that poor control was also 
common among nonvisitors. 
 Although mailing visitors an ACQ is a 
feasible way to identify suboptimal asthma 
control, as this study has demonstrated, we 
question the relevance of this approach for 
this group. Identiﬁ cation of poorly con-
trolled symptoms is only the initial step, 
and it should lead to better management. 
For these visitors, a more efﬁ cient approach 
would in all probability be to include the 
ACQ in their regular follow-up visits. Judg-
ing from our ﬁ ndings, that approach would 
identify the largest number of patients with 
poorly controlled asthma in the family 
practice population.
Mailing the ACQ does 
make sense for the population 
of patients who have asthma 
but do not make regular asthma 
visits to their family physician. 
Our ﬁ ndings conﬁ rm that this is 
a substantial proportion of the 
asthma population. An interest-
ing area for further study would 
be the follow-up on this ﬁ nding. 
A logical next step for the non-
visitors would be to invite those 
with high ACQ sum scores (eg, 
>3 points) to visit their family 
physician or practice nurse. This 
visit could be used to identify 
yet unidentiﬁ ed triggers for the 
poor asthma symptom control, 
discuss the patients’ personal 
preferences, and evaluate their 
current asthma management, 
Table 3. Characteristics of Primary Respondents 
and Secondary Respondents
Characteristic
Primary 
Respondents
(n = 244)
Secondary 
Respondents
(n = 89) P Value
Female 65.2 (159) 55.1 (49) .09*
Age, mean (SD), years 34.6 (7.3) 34.6 (8.1) .94†
Visitors‡ 50.4 (123) 40.4 (36) .11*
Consultations,§ mean (SD), No. 1.3 (2.1) 0.8 (1.2) .03ll 
Use of any asthma medication¶ 83.2 (203) 69.7 (62) .007*
Asthma exacerbation# 13.9 (34) 10.1 (9) .46*
ACQ sum score, mean (SD) 5.3 (5.3) 4.8 (5.2) .49ll
ACQ = Asthma Control Questionnaire.14,16
Note: Values are % (No.) unless indicated otherwise.
* Calculated with χ2 test.
† Calculated with 1-way analysis of variance test.
‡ Patients who visited their family physician for respiratory complaints, including visits for 
asthma exacerbations.
§ In the 2 years preceding ACQ mailing. Calculated with Mann-Whitney U test.
¶ At least 1 prescription for a bronchodilator or an inhaled steroid in the 2 years preceding the 
ACQ mailing.
# At least 1 exacerbation for which prednisolone or antibiotics were prescribed.
Figure 2. Distribution of ACQ sum scores among all respondents 
with a complete ACQ (n = 326). 
ACQ = Asthma Control Questionnaire.14,16
Note: Dashed line indicates ACQ cutoff value for asthma patients with suboptimal asthma symptom control 
(>3 points).13
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which is likely to offer substantial room for improve-
ment.22,23 As 57% of the nonvisitors have well-con-
trolled symptoms and do not need an extra visit, the 
ACQ can therefore be used to efﬁ ciently identify 
which nonvisitors need extra attention. We expect, 
however, that fewer patients with suboptimally con-
trolled asthma will be found among the nonvisitors 
than among the visitors. As the nonvisitors did not 
visit their family physician on their own initiative, one 
might ask whether they would respond to an invitation 
to an asthma review; however, their completion of the 
ACQ might indicate that they are not unwilling but 
only unaware of their poor asthma control. This would 
be an interesting area for further study.
In this study, we evaluated a postal mailing with 
a single reminder mailing after 4 weeks in the case of 
initial nonresponse. We considered this approach to 
be feasible for any family practice. More than one-
half of all approached patients responded to the initial 
questionnaire mailing, and the response rate further 
increased to three-quarters of all approached patients 
after a reminder was sent. 
Secondary respondents did not have more asthma 
problems than primary respondents. One might have 
expected that patients who were reluctant to respond 
to a health questionnaire would also be reluctant to 
follow treatment. But judging from the rates of poor 
asthma control, there are no indications that second-
ary respondents fared worse in their asthma (self-) 
management. It would be interesting to know how 
this ﬁ nding relates to that among patients who did not 
respond at all to the ACQ. Although we regard our 
response rate to be satisfactory, no information on the 
current level of symptom control could be gathered in 
1 of every 4 asthma patients. Relative to respondents, 
nonrespondents were more likely to be male and were 
less likely to use inhaled corticosteroids. Other inves-
tigators have also reported that men are less likely 
than women to respond to postal mailings.24,25 It has 
been suggested that when using symptom-orientated 
questionnaires, individuals with health problems may 
respond more often than those without.26 On the 
other hand, a report from an epidemiologic study on 
respiratory health found that nonrespondents experi-
enced more respiratory symptoms than respondents 
did.25 It is therefore possible that some of the asthma 
patients in our study who did not return questionnaires 
experienced more symptoms than their responding 
counterparts, and their lack of response may have 
concealed a poor level of asthma control among the 
nonrespondents. The information obtained from the 
medical records did not, however, point to a higher 
rate among the nonrespondents of respiratory-related 
family physician consultations, hospitalizations, or 
emergency department visits for asthma, or respiratory 
medication use.
When selecting patients with asthma for inclusion 
in this study, we could use only the information that 
was routinely recorded in the family physicians’ com-
puterized patient journal system. We could therefore 
not verify if every patient on the mailing list actually 
met the current national27 or international20 diagnostic 
criteria for asthma. Because patient records may not 
always be up to date with regard to the labels attached, 
our reliance on records may have led to some misclas-
siﬁ cation of patients selected for the mailing. 
In conclusion, we found that the majority of adult 
asthma patients registered in Dutch family practices 
responded to a postal mailing with a short question-
naire regarding asthma symptom control—in our 
case, the ACQ. This mailing reached asthma patients 
who would otherwise not have come to the atten-
tion of the family physician. In this group of patients, 
there certainly seemed to be room for improvement 
in management given the apparently high prevalence 
of suboptimal control of their asthma symptoms. Our 
ﬁ ndings suggest that a postal mailing of the ACQ may 
be an appropriate starting point for identifying patients 
in a family practice who have suboptimal control of 
asthma symptoms.
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